Avoro Capital is a global life sciences investment firm based in New York, NY, specializing in supporting emerging biotechnology companies. With a comprehensive approach, they seek out scientific breakthroughs that can address unmet medical needs and identify unique investment opportunities in the biotech sector.
With a focus on risk management, Avoro Capital carefully assesses macro and company-specific risks, employing portfolio construction strategies that include tactical and fundamental hedges. Their goal is to provide financial and intellectual support to companies throughout the investment lifecycle, contributing to the advancement of biopharmaceutical innovation.
Generated from the website